Entrada Therapeutics, Inc. (TRDA) — SC 13D/A Filings
All SC 13D/A filings from Entrada Therapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Baker Bros. Advisors Amends Entrada Therapeutics Stake
— Jun 26, 2024 Risk: medium
Baker Bros. Advisors LP, through its general partner Baker Bros. Advisors (GP) LLC and principals Felix J. Baker and Julian C. Baker, filed an amendment on June
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX